Trials / Completed
CompletedNCT01391312
Patient Satisfaction Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Frown Lines
A Pilot Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Glabellar Lines - Establishing Patient Satisfaction
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Allergan · Industry
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This was a pilot study to observe patient satisfaction with BOTOX® Cosmetic treatment in glabellar rhytides (frown lines) using a new treatment satisfaction measure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | botulinum toxin Type A | botulinum toxin Type A 20U (total dose) injected into the glabellar region on Day 0. |
| DRUG | normal saline (placebo) | Normal saline (placebo) injected into the glabellar region on Day 0. |
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2011-10-01
- Completion
- 2011-10-01
- First posted
- 2011-07-12
- Last updated
- 2012-09-25
- Results posted
- 2012-09-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01391312. Inclusion in this directory is not an endorsement.